2Semana
But the company hasn't done anything wrong, stupidly speaking, has it? They have a real business, so even this horror news can't turn the company off? Total loss and all that?
•
11
•
2Semana
@PikaPika0105 well, an arrest is already a different house number, apparently not everything is correct after all
••
2Semana
@Nemesis1990 So not everything is going well, but the business still exists and the partners like Henkel. Yesterday there was also news about the Chinese partners.
•
11
•2Semana
@PikaPika0105 Are they all true? We don't know, we can only observe .... If it is tradable again I will sell immediately .
•
11
•2Semana
@Nemesis1990 This would be very easy to check and if news outlets were reporting on it and it wasn't true, the companies in question would certainly have come forward long ago.
••
2Semana
@PikaPika0105 That is the good assumption. Unfortunately, the more likely assumption is that the CEO has set up letterbox companies via middlemen and that these businesses do not exist.
••
2Semana
@Multibagger Das halte ich für unwahrscheinlich. Wenn die Geschäfte nicht existieren würden hätten das Henkel und Likang wohl bereits angemerkt.
Das ist ein Artikel von vor zwei Tagen zur Partnerschaft mit den Chinesen:
Intellego Technologies AB ("Intellego") announces that its partner, Shanghai Zhongyou Medical High Tech Co., Ltd ("LiKang"), continues to purchase Intellego's UV dosimeter products in China following positive feedback from the market. These purchases relate to Intellego's standardized UV dosimeters which are not classified as medical devices. LiKang has been selling Intellego's standard dosimeter products during the past year, and more than 1,000 hospitals have started to implement Intellego's products to quality-assure UV disinfection processes.
The use of UV disinfection is currently subject to a regulatory revision in China, which is expected to make the use of verification products such as Intellego's dosimeters mandatory. These factors, combined with strong market feedback and a growing customer base, have contributed to LiKang's increased order activity.
November 2025, Intellego's CEO, Claes Lindahl, and Chairman of the Board, Gregory Batcheller, visited LiKang in China to discuss the ongoing collaboration and future expansion. Over the past year, LiKang has carried out extensive market development work and collected substantial feedback from end users, indicating strong customer satisfaction and market potential:
95% of hospitals use colour indicators to verify UV exposure levels, while 3% use radiometers.
Approximately 88% of users of Intellego's dosimeters report being very satisfied with the products.
Around 60% consider Intellego's dosimeters significantly better than competing products, 35% find them somewhat better, and 5% rated Intellego's products below the competition.
Intellego's dosimeters are now in use at more than 1,000 hospitals in China.
A dedicated app system for the disinfection market is under review.
Regulatory revision expected in 2026, which would make the use of verification products like Intellego's mandatory on a continuous basis.
For 2026 and onwards, the sales will continue to increase based on the estimation that a hospital will spend between USD 10,000 and 20,000 per month on colour indicators to verify UV disinfection.
Das ist ein Artikel von vor zwei Tagen zur Partnerschaft mit den Chinesen:
Intellego Technologies AB ("Intellego") announces that its partner, Shanghai Zhongyou Medical High Tech Co., Ltd ("LiKang"), continues to purchase Intellego's UV dosimeter products in China following positive feedback from the market. These purchases relate to Intellego's standardized UV dosimeters which are not classified as medical devices. LiKang has been selling Intellego's standard dosimeter products during the past year, and more than 1,000 hospitals have started to implement Intellego's products to quality-assure UV disinfection processes.
The use of UV disinfection is currently subject to a regulatory revision in China, which is expected to make the use of verification products such as Intellego's dosimeters mandatory. These factors, combined with strong market feedback and a growing customer base, have contributed to LiKang's increased order activity.
November 2025, Intellego's CEO, Claes Lindahl, and Chairman of the Board, Gregory Batcheller, visited LiKang in China to discuss the ongoing collaboration and future expansion. Over the past year, LiKang has carried out extensive market development work and collected substantial feedback from end users, indicating strong customer satisfaction and market potential:
95% of hospitals use colour indicators to verify UV exposure levels, while 3% use radiometers.
Approximately 88% of users of Intellego's dosimeters report being very satisfied with the products.
Around 60% consider Intellego's dosimeters significantly better than competing products, 35% find them somewhat better, and 5% rated Intellego's products below the competition.
Intellego's dosimeters are now in use at more than 1,000 hospitals in China.
A dedicated app system for the disinfection market is under review.
Regulatory revision expected in 2026, which would make the use of verification products like Intellego's mandatory on a continuous basis.
For 2026 and onwards, the sales will continue to increase based on the estimation that a hospital will spend between USD 10,000 and 20,000 per month on colour indicators to verify UV disinfection.
••
2Semana
@PikaPika0105 if that was a lie and nobody bothered to correct it, that would be wild
••
2Semana
@PikaPika0105 I would love it if you were right, but it could also be as suggested in the video.
https://youtu.be/P2AoVylmOaI?si=g-QOaYcQ8QYKx310
https://youtu.be/P2AoVylmOaI?si=g-QOaYcQ8QYKx310
••
2Semana
@Multibagger This is older than your first post about them...... I'll take a look.
•
11
•2Semana
@PikaPika0105 Yes, he made a new one in his app yesterday. But unfortunately I can't copy it.
••